Matthew Goetz, MD

Matthew P. Goetz, MD, is an associate professor of oncology at the Mayo Clinic in Rochester, Minn., and a lead researcher on the BEAUTY Project, a study with the goal of identifying genetic mutations and cancer pathway changes before and after neoadjuvant chemotherapy (chemotherapy given before surgery).

Dr. Goetz’s primary research focuses on estrogen receptor-positive (ER-positive) breast cancer and developing new treatments for hormone receptor-positive breast cancers that resist hormonal therapies. He has devoted research to identifying specific genetic differences that may impact how well tamoxifen works in treating ER-positive breast cancer.

Dr. Goetz is deputy director of the Mayo Clinic’s SPORE study and chair of the Breast Disease-Oriented Group at the Mayo Clinic Cancer Center.